Duncan-Williams Downgrades eResearchTechnology (ERES) to Hold; Valuation Call
More News related to ERES
- ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009
- Duncan-Williams Downgrades eResearchTechnology (ERES) to Hold; Valuation Call
- After-Hours Movers 10/29: AXTI, ISSI, APKT, GNW, CEC, CSA, LVS Higher; IDIX, NVTL, TSRA, CRDC Lower
- eResearch Technology (ERES) Reports Q3 Earnings, Gudies Below for Q4 and FY
- ERT Reports Third Quarter 2009 Results
More News related to Downgrades
- United Community Financial (UCFC) and United Bancshares (UBOH) To Sell Findlay, OH Branch to The Union Bank Co.
- GE receives French notice that its Areva bid wasn't chosen
- Health Management Associates (HMA) Completes Acquisition of Sparks Health System
- Wright Medical (WMGI) Reports Favorable Ruling in Stryker (SYK) Patent Infringement Case
- United Rentals (URI) Awarded Purchasing Contracts in Massachusetts and Texas
Duncan-Williams downgrades eResearchTechnology (Nasdaq: ERES) to Hold.
Duncan analyst says, "We are downgrading ERES to a HOLD based on valuation. In our opinion, ERES has weathered the downturn in R&D spending, and the current stock price represents a fair valuation based on our revised revenue and EPS estimates. We look for improved business fundamentals and improved visibility in 2010. We believe ERES is a core holding in the Clinical Research Organization (CRO) sector...We are reducing our 2010 Service Revenue estimate to $73.8 million. Our 2010 Service Revenue estimate represents 15% growth compared to our 2009 estimate. We are reducing our 2010 Site Support Revenue estimate to $31.3 million. Our 2010 Site Support Revenue estimate represents 20% growth compared to our 2009 estimate."
To see more analyst ratings on ERES Click Here.
Related Categories
DowngradesStocks Mentioned
-0.07Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
